DiaSorin (OTCMKTS:DSRLF) Cut to “Hold” at UBS Group

UBS Group lowered shares of DiaSorin (OTCMKTS:DSRLFFree Report) from a strong-buy rating to a hold rating in a report issued on Tuesday morning,Zacks.com reports.

DiaSorin Stock Performance

Shares of OTCMKTS DSRLF opened at $107.88 on Tuesday. DiaSorin has a 52 week low of $107.88 and a 52 week high of $107.88. The business has a 50-day simple moving average of $103.07 and a two-hundred day simple moving average of $103.07.

About DiaSorin

(Get Free Report)

DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS.

Recommended Stories

Receive News & Ratings for DiaSorin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DiaSorin and related companies with MarketBeat.com's FREE daily email newsletter.